Brief: Relief Therapeutics And Acer Therapeutics Issue U.S. Patent 11,154,521 Covering ACER-001 Formulation

MindMaze Therapeutics Holding SA

26/10/2021 06:14

Oct 26 (Reuters) - RELIEF THERAPEUTICS HOLDING SA  RLFB.S :
    * ACER THERAPEUTICS AND RELIEF THERAPEUTICS ANNOUNCE
ISSUANCE OF
U.S. PATENT 11,154,521 COVERING ACER-001 FORMULATION
    * PATENT 11,154,521 COVERS PHARMACEUTICAL COMPOSITION CLAIMS
RELATED TO ACER-001'S TASTE-MASKED, MULTI-PARTICULATE DOSAGE
FORMULATION FOR ORAL ADMINISTRATION
    * NEWLY ISSUED PATENT HAS AN EXPIRATION DATE IN 2036

Source text for Eikon:  ID:nEQ2Sk5Qya 
Further company coverage:  RLFB.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))